Business
Parkinson & Movement Disorder (PMD) Alliance and Neurocrine Biosciences Announce New Survey Results Revealing the Significant Impact OFF Time Has on People with Parkinson's Disease and Their Care Partners
86 percent of people with Parkinson's disease (PD) (n=113) taking the survey experience OFF time daily, and a majority report it has a significant impact on
About this update from Neurocrine Biosciences, Inc.
[{"type":"text","content":"86 percent of people with Parkinson's disease (PD) (n=113) taking the survey experience OFF time daily, and a majority report it has a significant impact on activitiesWhile three in four people with PD (78%) report that their current treatment plan is effective at limiting their PD symptoms, over half (56%) also say that they don't think their symptoms can improve beyond their current stateSAN DIEGO, Sept. 12, 2022 /PRNewswire/ -- Parkinson & Movement Disorder (PMD) Alliance, in partnership with Neurocrine Biosciences (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company committed to meeting the needs of people with complex and debilitating disorders, today announced results from the Survey Assessment: Impact of OFF Time on People with Parkinson's Disease and Their Care Partners. Findings revealed that despite a majority of these people with Parkinson's disease (PD) and their care partners being significantly impacted by OFF time—a period of time when PD symptoms return between regular doses of carbidopa/levodopa medication—there is a general acceptance that the emergence of OFF time is part of the disease, and they may not be aware of the availability and use of adjunctive treatment options to address return of PD symptoms.\n\n \n \n \n \n \n \n\n \nThe survey was conducted by Ipsos, one of the largest market research and polling companies globally.\n\"At PMD Alliance, we are passionate about connecting directly with the PD community about their experiences, challenges, and strategies to live well after a diagnosis. We hear again and again about the impact of OFF time, from both people living with the disease, and their loved ones and care partners,\" said Andrea Merriam, Acting CEO, PMD Alliance. \"Good communication between families and healthcare providers is crucial to recognize the signs of OFF time and stay informed about adjunctive treatment options so intervention can occur early in the treatment plan, if needed.\"\nKey findings from the survey include:\nPeople with PD and Care Partners Should Discuss OFF Time Symptoms with a Healthcare ProviderAmong people with PD (n=113) taking the survey:\n86 percent of these people with Parkinson's disease experience OFF time daily, and a majority report it has a significant impact on activities.While three in four people with PD (78%) report that their current tr...